LIBERAL STUDIES Sample Clauses

LIBERAL STUDIES. NDNU agrees to accept the West Valley College courses listed below in satisfaciton of Liberal Studies major requirements. Each course can be used to fulfill only one requirement. For further information or to make an appointment with a transfer counselor, please contact the Admission Office.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
LIBERAL STUDIES. Many adult students opt to earn a degree in Liberal Studies because it allows for greater transferability of credits. The Liberal Studies major is a highly individualized program offered exclusively through Xxxxxx Xxxxxx College. Applicants who have attended other accredited colleges may transfer up to 60 credits for applicable courses in which a grade of "C" or better was earned. Students who qualify for this interdisciplinary degree program are permitted to earn as many as 30 semester hours for academically relevant experience as outlined by the catalog. In developing the areas of concentration, the student will select 3 or 4 fields of study, with at least 15 credits but not more than 24 credits in any single field. Careful attention must be given to selecting the areas of study as well as to determining the number of credits to be taken in each area selected. Thus, the student may be asked to seek advice from faculty members in several departments before drawing up a final degree plan. Up to 30 credits of business courses are allowed in the concentration areas, in keeping with AACSB accreditation guidelines.
Sample 1
LIBERAL STUDIES. NDNU agrees to accept the CCSF courses listed below in satisfaciton of Liberal Studies major requirements. Each course can be used to fulfill only one requirement. For further information or to make an appointment with a transfer counselor, please contact the Admission Office.
Sample 1
LIBERAL STUDIES. The Liberal Studies specialization available through Vancouver Island University focuses on encounters with some of the most enduring original works from various areas of thought and creative endeavour. By thinking about and discussing works from the history of (primarily) Western culture, students in liberal studies seek to gain deeper understanding of who we are and how our values and perspectives have been shaped by certain cultural legacies. Classes are taught primarily through seminars (small-group discussions among students and a professor) and offered at the Xxxxxx River, Cowichan and Nanaimo Campuses as well as the Comox Valley Campus of North Island College. Students in this specialization complete any two of the following courses: LBST 310 Modern Culture’s Ancient Sources (6 credits) LBST 320 Medieval and Renaissance Thought: Imagination, Reason, Faith (6 credits) LBST 410 The Enlightenment and its Aftermath (6 credits) LBST 420 The Modern Experience and Beyond (6 credits) This option will be available to BAIS students starting September 2014.
Sample 1
LIBERAL STUDIES. Up to 30 credits of business courses taken at Lackawanna College can be used in the Liberal Studies degree, in keeping with AACSB guidelines.
Sample 1

Related to LIBERAL STUDIES

  • Trials The Ship shall run the following test and trials:

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • The Study 2.1The parties must comply with, and conduct the Study in accordance with, the Protocol and any conditions of the Reviewing HREC. In addition the parties must comply with the following, as applicable:

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!